The cancer detection rate for prostate cancer in 2003 was 1.48% by population-based mass screening using prostate-specific antigen (PSA) testing.18 According to the national estimates, the incidence of prostate cancer significantly increased, especially from 2000, although mortality remains unchanged (1999–2006). Here, KLK3 is linked to prostate carcinoma.